Illumina Body Map 2: averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MAZ
|
ENSG00000103495.9 | MYC associated zinc finger protein |
ZNF281
|
ENSG00000162702.7 | zinc finger protein 281 |
GTF2F1
|
ENSG00000125651.9 | general transcription factor IIF subunit 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
GTF2F1 | hg19_v2_chr19_-_6393216_6393229 | 0.50 | 3.3e-03 | Click! |
MAZ | hg19_v2_chr16_+_29819372_29819442 | 0.19 | 3.1e-01 | Click! |
ZNF281 | hg19_v2_chr1_-_200379180_200379191 | -0.07 | 7.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr20_-_62103862 | 22.12 |
ENST00000344462.4
ENST00000357249.2 ENST00000359125.2 ENST00000360480.3 ENST00000370224.1 ENST00000344425.5 ENST00000354587.3 ENST00000359689.1 |
KCNQ2
|
potassium voltage-gated channel, KQT-like subfamily, member 2 |
chr7_+_128431444 | 20.54 |
ENST00000459946.1
ENST00000378685.4 ENST00000464832.1 ENST00000472049.1 ENST00000488925.1 |
CCDC136
|
coiled-coil domain containing 136 |
chr19_+_55795493 | 20.21 |
ENST00000309383.1
|
BRSK1
|
BR serine/threonine kinase 1 |
chr19_-_42573650 | 18.27 |
ENST00000593562.1
|
GRIK5
|
glutamate receptor, ionotropic, kainate 5 |
chr19_-_51071302 | 17.87 |
ENST00000389201.3
ENST00000600381.1 |
LRRC4B
|
leucine rich repeat containing 4B |
chr2_+_79740118 | 16.82 |
ENST00000496558.1
ENST00000451966.1 |
CTNNA2
|
catenin (cadherin-associated protein), alpha 2 |
chr19_-_47975106 | 16.56 |
ENST00000539381.1
ENST00000594353.1 ENST00000542837.1 |
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
chr19_-_291365 | 15.42 |
ENST00000591572.1
ENST00000269812.3 ENST00000434325.2 |
PPAP2C
|
phosphatidic acid phosphatase type 2C |
chr19_+_3224700 | 15.28 |
ENST00000292672.2
ENST00000541430.2 |
CELF5
|
CUGBP, Elav-like family member 5 |
chr11_-_64410787 | 14.74 |
ENST00000301894.2
|
NRXN2
|
neurexin 2 |
chr19_-_47975417 | 13.03 |
ENST00000236877.6
|
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
chr6_+_17393888 | 12.91 |
ENST00000493172.1
ENST00000465994.1 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr8_+_80523962 | 12.84 |
ENST00000518491.1
|
STMN2
|
stathmin-like 2 |
chr3_-_116164306 | 12.62 |
ENST00000490035.2
|
LSAMP
|
limbic system-associated membrane protein |
chr5_+_175298487 | 12.22 |
ENST00000393745.3
|
CPLX2
|
complexin 2 |
chr6_+_17393839 | 12.13 |
ENST00000489374.1
ENST00000378990.2 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr5_+_175298573 | 12.10 |
ENST00000512824.1
|
CPLX2
|
complexin 2 |
chr15_-_88799661 | 11.91 |
ENST00000360948.2
ENST00000357724.2 ENST00000355254.2 ENST00000317501.3 |
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3 |
chr16_-_49890016 | 11.87 |
ENST00000563137.2
|
ZNF423
|
zinc finger protein 423 |
chr16_-_30042580 | 11.75 |
ENST00000380495.4
|
FAM57B
|
family with sequence similarity 57, member B |
chr19_-_47975143 | 11.60 |
ENST00000597014.1
|
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
chr16_+_29911864 | 11.34 |
ENST00000308748.5
|
ASPHD1
|
aspartate beta-hydroxylase domain containing 1 |
chr12_+_58005204 | 11.20 |
ENST00000286494.4
|
ARHGEF25
|
Rho guanine nucleotide exchange factor (GEF) 25 |
chr9_-_122131696 | 10.97 |
ENST00000373964.2
ENST00000265922.3 |
BRINP1
|
bone morphogenetic protein/retinoic acid inducible neural-specific 1 |
chr17_+_42385927 | 10.90 |
ENST00000426726.3
ENST00000590941.1 ENST00000225441.7 |
RUNDC3A
|
RUN domain containing 3A |
chrX_+_101380642 | 10.86 |
ENST00000372780.1
ENST00000329035.2 |
TCEAL2
|
transcription elongation factor A (SII)-like 2 |
chr19_+_54412517 | 10.75 |
ENST00000391767.1
|
CACNG7
|
calcium channel, voltage-dependent, gamma subunit 7 |
chr19_-_291133 | 10.58 |
ENST00000327790.3
|
PPAP2C
|
phosphatidic acid phosphatase type 2C |
chr19_-_35626104 | 10.32 |
ENST00000310123.3
ENST00000392225.3 |
LGI4
|
leucine-rich repeat LGI family, member 4 |
chr2_-_220173685 | 10.13 |
ENST00000423636.2
ENST00000442029.1 ENST00000412847.1 |
PTPRN
|
protein tyrosine phosphatase, receptor type, N |
chr19_-_36523529 | 10.07 |
ENST00000593074.1
|
CLIP3
|
CAP-GLY domain containing linker protein 3 |
chr19_-_49149553 | 9.76 |
ENST00000084798.4
|
CA11
|
carbonic anhydrase XI |
chr20_+_34742650 | 9.32 |
ENST00000373945.1
ENST00000338074.2 |
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
chr14_+_29236269 | 9.20 |
ENST00000313071.4
|
FOXG1
|
forkhead box G1 |
chr15_-_37392703 | 9.19 |
ENST00000382766.2
ENST00000444725.1 |
MEIS2
|
Meis homeobox 2 |
chr4_-_168155169 | 9.17 |
ENST00000534949.1
ENST00000535728.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chrX_-_102319092 | 8.89 |
ENST00000372728.3
|
BEX1
|
brain expressed, X-linked 1 |
chr13_+_88324870 | 8.87 |
ENST00000325089.6
|
SLITRK5
|
SLIT and NTRK-like family, member 5 |
chr15_-_37392724 | 8.83 |
ENST00000424352.2
|
MEIS2
|
Meis homeobox 2 |
chr1_-_177133818 | 8.75 |
ENST00000424564.2
ENST00000361833.2 |
ASTN1
|
astrotactin 1 |
chr7_+_121513374 | 8.69 |
ENST00000449182.1
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
chr16_-_65155979 | 8.58 |
ENST00000562325.1
ENST00000268603.4 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
chr22_-_38380543 | 8.49 |
ENST00000396884.2
|
SOX10
|
SRY (sex determining region Y)-box 10 |
chr16_+_76311169 | 8.37 |
ENST00000307431.8
ENST00000377504.4 |
CNTNAP4
|
contactin associated protein-like 4 |
chr16_-_31021717 | 8.33 |
ENST00000565419.1
|
STX1B
|
syntaxin 1B |
chr3_+_115342159 | 8.30 |
ENST00000305124.6
|
GAP43
|
growth associated protein 43 |
chr11_-_64490634 | 8.27 |
ENST00000377559.3
ENST00000265459.6 |
NRXN2
|
neurexin 2 |
chr5_+_175298674 | 8.27 |
ENST00000514150.1
|
CPLX2
|
complexin 2 |
chr1_+_160085501 | 8.26 |
ENST00000361216.3
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
chr11_-_790060 | 8.24 |
ENST00000330106.4
|
CEND1
|
cell cycle exit and neuronal differentiation 1 |
chr8_-_144241664 | 8.23 |
ENST00000342752.4
|
LY6H
|
lymphocyte antigen 6 complex, locus H |
chr3_+_115342349 | 8.22 |
ENST00000393780.3
|
GAP43
|
growth associated protein 43 |
chr4_-_168155300 | 8.20 |
ENST00000541637.1
|
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chr19_-_6502341 | 8.15 |
ENST00000598006.1
ENST00000601152.1 |
TUBB4A
|
tubulin, beta 4A class IVa |
chr17_+_30594823 | 8.13 |
ENST00000536287.1
|
RHBDL3
|
rhomboid, veinlet-like 3 (Drosophila) |
chr7_+_153749732 | 8.07 |
ENST00000377770.3
|
DPP6
|
dipeptidyl-peptidase 6 |
chr11_-_111783595 | 8.02 |
ENST00000528628.1
|
CRYAB
|
crystallin, alpha B |
chr2_+_220306745 | 8.01 |
ENST00000431523.1
ENST00000396698.1 ENST00000396695.2 |
SPEG
|
SPEG complex locus |
chr22_+_51039098 | 7.97 |
ENST00000399912.1
ENST00000329492.3 ENST00000442429.2 ENST00000341339.4 |
MAPK8IP2
|
mitogen-activated protein kinase 8 interacting protein 2 |
chrX_-_151619746 | 7.95 |
ENST00000370314.4
|
GABRA3
|
gamma-aminobutyric acid (GABA) A receptor, alpha 3 |
chr6_-_29600832 | 7.88 |
ENST00000377016.4
ENST00000376977.3 ENST00000377034.4 |
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1 |
chr14_+_24540731 | 7.59 |
ENST00000558859.1
ENST00000559197.1 ENST00000560828.1 ENST00000216775.2 ENST00000560884.1 |
CPNE6
|
copine VI (neuronal) |
chr10_+_119302508 | 7.58 |
ENST00000442245.4
|
EMX2
|
empty spiracles homeobox 2 |
chr19_+_18723660 | 7.54 |
ENST00000262817.3
|
TMEM59L
|
transmembrane protein 59-like |
chr1_-_20812690 | 7.53 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr19_-_35625765 | 7.53 |
ENST00000591633.1
|
LGI4
|
leucine-rich repeat LGI family, member 4 |
chr2_+_115919684 | 7.52 |
ENST00000310323.8
|
DPP10
|
dipeptidyl-peptidase 10 (non-functional) |
chr4_-_5890145 | 7.46 |
ENST00000397890.2
|
CRMP1
|
collapsin response mediator protein 1 |
chr6_+_44238203 | 7.41 |
ENST00000451188.2
|
TMEM151B
|
transmembrane protein 151B |
chr9_-_35691017 | 7.41 |
ENST00000378292.3
|
TPM2
|
tropomyosin 2 (beta) |
chr14_-_24047965 | 7.37 |
ENST00000397118.3
ENST00000356300.4 |
JPH4
|
junctophilin 4 |
chr5_+_71014990 | 7.36 |
ENST00000296777.4
|
CARTPT
|
CART prepropeptide |
chr19_+_11650709 | 7.34 |
ENST00000586059.1
|
CNN1
|
calponin 1, basic, smooth muscle |
chr7_+_121513143 | 7.34 |
ENST00000393386.2
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
chr1_+_156611704 | 7.31 |
ENST00000329117.5
|
BCAN
|
brevican |
chr15_-_88799948 | 7.25 |
ENST00000394480.2
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3 |
chr4_-_6474173 | 7.25 |
ENST00000382599.4
|
PPP2R2C
|
protein phosphatase 2, regulatory subunit B, gamma |
chr5_+_175299743 | 7.22 |
ENST00000502265.1
|
CPLX2
|
complexin 2 |
chr16_+_87636474 | 7.21 |
ENST00000284262.2
|
JPH3
|
junctophilin 3 |
chr12_-_6809958 | 7.20 |
ENST00000320591.5
ENST00000534837.1 |
PIANP
|
PILR alpha associated neural protein |
chr11_+_125034586 | 7.17 |
ENST00000298282.9
|
PKNOX2
|
PBX/knotted 1 homeobox 2 |
chr7_-_32111009 | 7.16 |
ENST00000396184.3
ENST00000396189.2 ENST00000321453.7 |
PDE1C
|
phosphodiesterase 1C, calmodulin-dependent 70kDa |
chrX_+_103031758 | 7.13 |
ENST00000303958.2
ENST00000361621.2 |
PLP1
|
proteolipid protein 1 |
chr12_-_6809543 | 7.08 |
ENST00000540656.1
|
PIANP
|
PILR alpha associated neural protein |
chr2_+_115919049 | 7.07 |
ENST00000393147.2
|
DPP10
|
dipeptidyl-peptidase 10 (non-functional) |
chr8_+_24771265 | 7.03 |
ENST00000518131.1
ENST00000437366.2 |
NEFM
|
neurofilament, medium polypeptide |
chr4_-_168155730 | 7.02 |
ENST00000502330.1
ENST00000357154.3 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chr10_+_119301928 | 6.99 |
ENST00000553456.3
|
EMX2
|
empty spiracles homeobox 2 |
chr1_-_151689259 | 6.98 |
ENST00000420342.1
ENST00000290583.4 |
CELF3
|
CUGBP, Elav-like family member 3 |
chr20_+_17207636 | 6.92 |
ENST00000262545.2
|
PCSK2
|
proprotein convertase subtilisin/kexin type 2 |
chr17_+_70117153 | 6.89 |
ENST00000245479.2
|
SOX9
|
SRY (sex determining region Y)-box 9 |
chr20_+_5892037 | 6.86 |
ENST00000378961.4
|
CHGB
|
chromogranin B (secretogranin 1) |
chr19_-_51222707 | 6.85 |
ENST00000391814.1
|
SHANK1
|
SH3 and multiple ankyrin repeat domains 1 |
chr6_+_1389989 | 6.83 |
ENST00000259806.1
|
FOXF2
|
forkhead box F2 |
chr16_-_65155833 | 6.82 |
ENST00000566827.1
ENST00000394156.3 ENST00000562998.1 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
chrX_-_49056635 | 6.80 |
ENST00000472598.1
ENST00000538567.1 ENST00000479808.1 ENST00000263233.4 |
SYP
|
synaptophysin |
chr20_+_10199468 | 6.80 |
ENST00000254976.2
ENST00000304886.2 |
SNAP25
|
synaptosomal-associated protein, 25kDa |
chr17_-_7120525 | 6.76 |
ENST00000447163.1
ENST00000399506.2 ENST00000302955.6 |
DLG4
|
discs, large homolog 4 (Drosophila) |
chr7_-_79082867 | 6.76 |
ENST00000419488.1
ENST00000354212.4 |
MAGI2
|
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
chr19_-_6502304 | 6.75 |
ENST00000540257.1
ENST00000594276.1 ENST00000594075.1 ENST00000600216.1 ENST00000596926.1 |
TUBB4A
|
tubulin, beta 4A class IVa |
chr17_+_30593195 | 6.74 |
ENST00000431505.2
ENST00000269051.4 ENST00000538145.1 |
RHBDL3
|
rhomboid, veinlet-like 3 (Drosophila) |
chr19_-_55660561 | 6.72 |
ENST00000587758.1
ENST00000356783.5 ENST00000291901.8 ENST00000588426.1 ENST00000588147.1 ENST00000536926.1 ENST00000588981.1 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr15_-_74043816 | 6.70 |
ENST00000379822.4
|
C15orf59
|
chromosome 15 open reading frame 59 |
chr12_+_106976678 | 6.68 |
ENST00000392842.1
|
RFX4
|
regulatory factor X, 4 (influences HLA class II expression) |
chr19_+_50194360 | 6.68 |
ENST00000323446.5
ENST00000392518.4 ENST00000598396.1 ENST00000598293.1 ENST00000354199.5 ENST00000405931.2 ENST00000602019.1 |
CPT1C
|
carnitine palmitoyltransferase 1C |
chrX_-_114468605 | 6.65 |
ENST00000538422.1
ENST00000317135.8 |
LRCH2
|
leucine-rich repeats and calponin homology (CH) domain containing 2 |
chr17_+_64961026 | 6.65 |
ENST00000262138.3
|
CACNG4
|
calcium channel, voltage-dependent, gamma subunit 4 |
chr3_+_96533413 | 6.62 |
ENST00000470610.2
ENST00000389672.5 |
EPHA6
|
EPH receptor A6 |
chr1_+_160085567 | 6.60 |
ENST00000392233.3
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
chr12_+_49212514 | 6.59 |
ENST00000301050.2
ENST00000548279.1 ENST00000547230.1 |
CACNB3
|
calcium channel, voltage-dependent, beta 3 subunit |
chr17_-_7120498 | 6.58 |
ENST00000485100.1
|
DLG4
|
discs, large homolog 4 (Drosophila) |
chrX_+_119030118 | 6.55 |
ENST00000371422.1
ENST00000334356.2 |
AKAP14
|
A kinase (PRKA) anchor protein 14 |
chr7_-_150675372 | 6.54 |
ENST00000262186.5
|
KCNH2
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
chr4_-_96470350 | 6.52 |
ENST00000504962.1
ENST00000453304.1 ENST00000506749.1 |
UNC5C
|
unc-5 homolog C (C. elegans) |
chrX_+_152783131 | 6.51 |
ENST00000349466.2
ENST00000370186.1 |
ATP2B3
|
ATPase, Ca++ transporting, plasma membrane 3 |
chr5_-_87980753 | 6.49 |
ENST00000511014.2
|
LINC00461
|
long intergenic non-protein coding RNA 461 |
chr19_-_47922373 | 6.47 |
ENST00000559524.1
ENST00000557833.1 ENST00000558555.1 ENST00000561293.1 ENST00000441740.2 |
MEIS3
|
Meis homeobox 3 |
chr9_+_109625378 | 6.43 |
ENST00000277225.5
ENST00000457913.1 ENST00000472574.1 |
ZNF462
|
zinc finger protein 462 |
chr19_-_51143075 | 6.40 |
ENST00000600079.1
ENST00000593901.1 |
SYT3
|
synaptotagmin III |
chr20_+_17207665 | 6.39 |
ENST00000536609.1
|
PCSK2
|
proprotein convertase subtilisin/kexin type 2 |
chr4_+_30721968 | 6.39 |
ENST00000361762.2
|
PCDH7
|
protocadherin 7 |
chr14_+_29234870 | 6.34 |
ENST00000382535.3
|
FOXG1
|
forkhead box G1 |
chr2_+_210636697 | 6.34 |
ENST00000439458.1
ENST00000272845.6 |
UNC80
|
unc-80 homolog (C. elegans) |
chr19_+_38880695 | 6.33 |
ENST00000587947.1
ENST00000338502.4 |
SPRED3
|
sprouty-related, EVH1 domain containing 3 |
chr1_-_1475737 | 6.32 |
ENST00000378733.4
ENST00000425828.1 |
TMEM240
|
transmembrane protein 240 |
chr14_-_27066636 | 6.28 |
ENST00000267422.7
ENST00000344429.5 ENST00000574031.1 ENST00000465357.2 ENST00000547619.1 |
NOVA1
|
neuro-oncological ventral antigen 1 |
chr19_-_2721412 | 6.24 |
ENST00000323469.4
|
DIRAS1
|
DIRAS family, GTP-binding RAS-like 1 |
chr19_+_12949251 | 6.23 |
ENST00000251472.4
|
MAST1
|
microtubule associated serine/threonine kinase 1 |
chr8_-_110986918 | 6.21 |
ENST00000297404.1
|
KCNV1
|
potassium channel, subfamily V, member 1 |
chr14_+_24837226 | 6.18 |
ENST00000554050.1
ENST00000554903.1 ENST00000554779.1 ENST00000250373.4 ENST00000553708.1 |
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
chr19_-_51054299 | 6.18 |
ENST00000599957.1
|
LRRC4B
|
leucine rich repeat containing 4B |
chr2_+_17721937 | 6.16 |
ENST00000451533.1
|
VSNL1
|
visinin-like 1 |
chr8_+_143530791 | 6.15 |
ENST00000517894.1
|
BAI1
|
brain-specific angiogenesis inhibitor 1 |
chrX_+_119029800 | 6.15 |
ENST00000371431.3
ENST00000371423.2 ENST00000371425.4 ENST00000394594.2 |
AKAP14
|
A kinase (PRKA) anchor protein 14 |
chr6_-_110500826 | 6.14 |
ENST00000265601.3
ENST00000447287.1 ENST00000444391.1 |
WASF1
|
WAS protein family, member 1 |
chr5_-_146833485 | 6.10 |
ENST00000398514.3
|
DPYSL3
|
dihydropyrimidinase-like 3 |
chr12_+_7023735 | 6.09 |
ENST00000538763.1
ENST00000544774.1 ENST00000545045.2 |
ENO2
|
enolase 2 (gamma, neuronal) |
chr12_+_3600356 | 6.09 |
ENST00000382622.3
|
PRMT8
|
protein arginine methyltransferase 8 |
chr19_+_41036371 | 6.03 |
ENST00000392023.1
|
SPTBN4
|
spectrin, beta, non-erythrocytic 4 |
chr2_+_220325441 | 6.03 |
ENST00000396688.1
|
SPEG
|
SPEG complex locus |
chr14_-_23834411 | 6.02 |
ENST00000429593.2
|
EFS
|
embryonal Fyn-associated substrate |
chr17_+_43861680 | 5.99 |
ENST00000314537.5
|
CRHR1
|
corticotropin releasing hormone receptor 1 |
chr20_-_21494654 | 5.98 |
ENST00000377142.4
|
NKX2-2
|
NK2 homeobox 2 |
chr19_-_36523709 | 5.98 |
ENST00000592017.1
ENST00000360535.4 |
CLIP3
|
CAP-GLY domain containing linker protein 3 |
chr11_+_125034640 | 5.97 |
ENST00000542175.1
|
PKNOX2
|
PBX/knotted 1 homeobox 2 |
chr5_-_87980587 | 5.96 |
ENST00000509783.1
ENST00000509405.1 ENST00000506978.1 ENST00000509265.1 ENST00000513805.1 |
LINC00461
|
long intergenic non-protein coding RNA 461 |
chr14_-_21994337 | 5.95 |
ENST00000537235.1
ENST00000450879.2 |
SALL2
|
spalt-like transcription factor 2 |
chr19_-_46476791 | 5.95 |
ENST00000263257.5
|
NOVA2
|
neuro-oncological ventral antigen 2 |
chr2_+_171673072 | 5.94 |
ENST00000358196.3
ENST00000375272.1 |
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa) |
chr16_-_30022735 | 5.93 |
ENST00000564944.1
|
DOC2A
|
double C2-like domains, alpha |
chr14_+_24540761 | 5.87 |
ENST00000559207.1
|
CPNE6
|
copine VI (neuronal) |
chrX_-_130423240 | 5.85 |
ENST00000370910.1
ENST00000370901.4 |
IGSF1
|
immunoglobulin superfamily, member 1 |
chr5_+_131593364 | 5.84 |
ENST00000253754.3
ENST00000379018.3 |
PDLIM4
|
PDZ and LIM domain 4 |
chr11_-_111784005 | 5.81 |
ENST00000527899.1
|
CRYAB
|
crystallin, alpha B |
chr1_-_26232522 | 5.80 |
ENST00000399728.1
|
STMN1
|
stathmin 1 |
chr6_-_29595779 | 5.79 |
ENST00000355973.3
ENST00000377012.4 |
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1 |
chr17_-_37353950 | 5.78 |
ENST00000394310.3
ENST00000394303.3 ENST00000344140.5 |
CACNB1
|
calcium channel, voltage-dependent, beta 1 subunit |
chr6_+_12749657 | 5.78 |
ENST00000406205.2
|
PHACTR1
|
phosphatase and actin regulator 1 |
chr19_+_50194821 | 5.77 |
ENST00000594587.1
ENST00000595969.1 |
CPT1C
|
carnitine palmitoyltransferase 1C |
chr4_-_46391805 | 5.77 |
ENST00000540012.1
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
chr9_+_137987825 | 5.77 |
ENST00000545657.1
|
OLFM1
|
olfactomedin 1 |
chr6_+_121756809 | 5.74 |
ENST00000282561.3
|
GJA1
|
gap junction protein, alpha 1, 43kDa |
chrX_+_102631844 | 5.72 |
ENST00000372634.1
ENST00000299872.7 |
NGFRAP1
|
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr5_-_146833222 | 5.70 |
ENST00000534907.1
|
DPYSL3
|
dihydropyrimidinase-like 3 |
chr12_+_57943781 | 5.69 |
ENST00000455537.2
ENST00000286452.5 |
KIF5A
|
kinesin family member 5A |
chr16_+_14396121 | 5.67 |
ENST00000570945.1
|
RP11-65J21.3
|
RP11-65J21.3 |
chr8_-_22089533 | 5.66 |
ENST00000321613.3
|
PHYHIP
|
phytanoyl-CoA 2-hydroxylase interacting protein |
chr11_-_111782696 | 5.66 |
ENST00000227251.3
ENST00000526180.1 |
CRYAB
|
crystallin, alpha B |
chr12_-_50297638 | 5.66 |
ENST00000320634.3
|
FAIM2
|
Fas apoptotic inhibitory molecule 2 |
chr8_-_144242020 | 5.64 |
ENST00000414417.2
|
LY6H
|
lymphocyte antigen 6 complex, locus H |
chrX_-_152939133 | 5.64 |
ENST00000370150.1
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
chr22_+_48972118 | 5.61 |
ENST00000358295.5
|
FAM19A5
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A5 |
chr17_-_42277203 | 5.58 |
ENST00000587097.1
|
ATXN7L3
|
ataxin 7-like 3 |
chr4_-_46391931 | 5.56 |
ENST00000381620.4
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
chr7_+_43152212 | 5.55 |
ENST00000453890.1
|
HECW1
|
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 |
chr6_-_110500905 | 5.55 |
ENST00000392587.2
|
WASF1
|
WAS protein family, member 1 |
chr12_+_53491220 | 5.50 |
ENST00000548547.1
ENST00000301464.3 |
IGFBP6
|
insulin-like growth factor binding protein 6 |
chr16_-_10276611 | 5.49 |
ENST00000396573.2
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
chr3_+_6902794 | 5.49 |
ENST00000357716.4
ENST00000486284.1 ENST00000389336.4 ENST00000403881.1 ENST00000402647.2 |
GRM7
|
glutamate receptor, metabotropic 7 |
chr4_-_168155700 | 5.48 |
ENST00000357545.4
ENST00000512648.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chrX_-_128657457 | 5.48 |
ENST00000371121.3
ENST00000371123.1 ENST00000371122.4 |
SMARCA1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
chr7_-_79082786 | 5.45 |
ENST00000522391.1
|
MAGI2
|
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
chr1_+_160160283 | 5.45 |
ENST00000368079.3
|
CASQ1
|
calsequestrin 1 (fast-twitch, skeletal muscle) |
chr15_-_66545995 | 5.45 |
ENST00000395614.1
ENST00000288745.3 ENST00000422354.1 ENST00000395625.2 ENST00000360698.4 ENST00000409699.2 |
MEGF11
|
multiple EGF-like-domains 11 |
chr18_-_35145593 | 5.44 |
ENST00000334919.5
ENST00000591282.1 ENST00000588597.1 |
CELF4
|
CUGBP, Elav-like family member 4 |
chr2_+_105471969 | 5.44 |
ENST00000361360.2
|
POU3F3
|
POU class 3 homeobox 3 |
chrX_+_117957741 | 5.43 |
ENST00000310164.2
|
ZCCHC12
|
zinc finger, CCHC domain containing 12 |
chr1_+_203096831 | 5.41 |
ENST00000337894.4
|
ADORA1
|
adenosine A1 receptor |
chr7_-_4998802 | 5.40 |
ENST00000406755.1
ENST00000404774.3 ENST00000401401.3 |
MMD2
|
monocyte to macrophage differentiation-associated 2 |
chr3_+_11034403 | 5.40 |
ENST00000287766.4
ENST00000425938.1 |
SLC6A1
|
solute carrier family 6 (neurotransmitter transporter), member 1 |
chr1_+_20878932 | 5.39 |
ENST00000332947.4
|
FAM43B
|
family with sequence similarity 43, member B |
chr4_-_168155417 | 5.39 |
ENST00000511269.1
ENST00000506697.1 ENST00000512042.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chr7_+_100081542 | 5.37 |
ENST00000300179.2
ENST00000423930.1 |
NYAP1
|
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 1 |
chr2_+_39893043 | 5.37 |
ENST00000281961.2
|
TMEM178A
|
transmembrane protein 178A |
chrX_+_103031421 | 5.35 |
ENST00000433491.1
ENST00000418604.1 ENST00000443502.1 |
PLP1
|
proteolipid protein 1 |
chr19_+_54385439 | 5.34 |
ENST00000536044.1
ENST00000540413.1 ENST00000263431.3 ENST00000419486.1 |
PRKCG
|
protein kinase C, gamma |
chr18_-_35145689 | 5.34 |
ENST00000591287.1
ENST00000601019.1 ENST00000601392.1 |
CELF4
|
CUGBP, Elav-like family member 4 |
chr7_+_94285637 | 5.33 |
ENST00000482108.1
ENST00000488574.1 |
PEG10
|
paternally expressed 10 |
chrX_+_100333709 | 5.32 |
ENST00000372930.4
|
TMEM35
|
transmembrane protein 35 |
chrX_+_144899416 | 5.32 |
ENST00000447897.2
|
SLITRK2
|
SLIT and NTRK-like family, member 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.6 | 26.5 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
6.1 | 24.3 | GO:0048687 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
5.0 | 14.9 | GO:1903280 | negative regulation of calcium:sodium antiporter activity(GO:1903280) |
4.4 | 39.6 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
4.1 | 8.2 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
3.7 | 11.2 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
3.7 | 14.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
3.7 | 11.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
3.5 | 10.5 | GO:0033058 | directional locomotion(GO:0033058) |
3.5 | 3.5 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
3.0 | 18.2 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
3.0 | 9.1 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
3.0 | 9.0 | GO:0072034 | renal vesicle induction(GO:0072034) |
3.0 | 11.9 | GO:1990502 | dense core granule maturation(GO:1990502) |
2.9 | 8.7 | GO:2001035 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
2.9 | 2.9 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
2.9 | 8.7 | GO:0050894 | determination of affect(GO:0050894) |
2.8 | 8.4 | GO:1904530 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
2.8 | 11.1 | GO:0098942 | cytoskeletal matrix organization at active zone(GO:0048789) neurexin clustering involved in presynaptic membrane assembly(GO:0097115) retrograde trans-synaptic signaling by trans-synaptic protein complex(GO:0098942) |
2.8 | 11.0 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
2.7 | 61.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
2.7 | 13.3 | GO:0030070 | insulin processing(GO:0030070) |
2.7 | 8.0 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
2.6 | 23.7 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
2.6 | 5.2 | GO:2000793 | cell proliferation involved in heart valve development(GO:2000793) |
2.6 | 10.3 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
2.6 | 17.9 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
2.5 | 7.6 | GO:0040040 | thermosensory behavior(GO:0040040) |
2.5 | 10.1 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
2.5 | 7.4 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
2.4 | 16.5 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
2.3 | 31.8 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.3 | 15.8 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
2.1 | 2.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
2.1 | 21.2 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
2.1 | 10.5 | GO:1903282 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
2.1 | 18.8 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
2.0 | 14.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
2.0 | 7.9 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
2.0 | 5.9 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
2.0 | 5.9 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
2.0 | 9.8 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.9 | 1.9 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.9 | 15.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.9 | 3.8 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.9 | 97.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.9 | 44.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.9 | 9.3 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
1.8 | 14.6 | GO:0003322 | pancreatic A cell development(GO:0003322) |
1.8 | 17.6 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
1.8 | 15.8 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.7 | 7.0 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
1.7 | 6.7 | GO:0072134 | nephrogenic mesenchyme morphogenesis(GO:0072134) |
1.7 | 18.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.7 | 23.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
1.7 | 3.4 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.7 | 6.7 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
1.7 | 10.0 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
1.7 | 26.6 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
1.6 | 37.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
1.6 | 33.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.6 | 4.8 | GO:2000374 | regulation of hydrogen peroxide catabolic process(GO:2000295) negative regulation of hydrogen peroxide catabolic process(GO:2000296) regulation of oxygen metabolic process(GO:2000374) |
1.6 | 36.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.6 | 6.3 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
1.6 | 14.1 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
1.6 | 3.1 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
1.6 | 4.7 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
1.5 | 3.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
1.5 | 6.2 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
1.5 | 1.5 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
1.5 | 29.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.5 | 7.6 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
1.5 | 4.5 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
1.5 | 6.0 | GO:0009956 | radial pattern formation(GO:0009956) |
1.5 | 9.0 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
1.5 | 4.5 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.5 | 4.5 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
1.5 | 9.0 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.5 | 6.0 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
1.5 | 8.9 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.5 | 4.4 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
1.5 | 2.9 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
1.5 | 4.4 | GO:0008057 | eye pigment granule organization(GO:0008057) |
1.4 | 7.2 | GO:0048749 | compound eye development(GO:0048749) |
1.4 | 4.3 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
1.4 | 5.7 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
1.4 | 4.3 | GO:0072720 | cellular response to mycotoxin(GO:0036146) response to dithiothreitol(GO:0072720) |
1.4 | 4.2 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
1.4 | 4.2 | GO:0021626 | hindbrain maturation(GO:0021578) pons maturation(GO:0021586) central nervous system maturation(GO:0021626) |
1.4 | 2.8 | GO:0031133 | regulation of axon diameter(GO:0031133) |
1.4 | 2.8 | GO:0048690 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
1.4 | 4.1 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
1.4 | 1.4 | GO:0008356 | asymmetric cell division(GO:0008356) |
1.4 | 11.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.4 | 6.8 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
1.4 | 2.7 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
1.3 | 6.7 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
1.3 | 5.4 | GO:0060262 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
1.3 | 6.7 | GO:0072166 | posterior mesonephric tubule development(GO:0072166) |
1.3 | 2.7 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
1.3 | 1.3 | GO:0060594 | mammary gland specification(GO:0060594) |
1.3 | 7.7 | GO:0030421 | defecation(GO:0030421) |
1.3 | 15.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.3 | 3.9 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
1.3 | 3.9 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
1.3 | 1.3 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
1.3 | 3.8 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
1.3 | 1.3 | GO:1990709 | presynaptic active zone organization(GO:1990709) |
1.3 | 7.6 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
1.3 | 7.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.3 | 5.0 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
1.3 | 25.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.3 | 3.8 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
1.3 | 16.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
1.2 | 17.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
1.2 | 11.2 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.2 | 1.2 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.2 | 3.7 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
1.2 | 3.6 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
1.2 | 2.4 | GO:0044467 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
1.2 | 4.8 | GO:0032773 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
1.2 | 5.9 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
1.2 | 13.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.2 | 2.4 | GO:0035106 | operant conditioning(GO:0035106) |
1.2 | 20.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.2 | 2.3 | GO:0035566 | regulation of metanephros size(GO:0035566) |
1.2 | 2.3 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.1 | 9.2 | GO:0019236 | response to pheromone(GO:0019236) |
1.1 | 5.7 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
1.1 | 41.1 | GO:0035640 | exploration behavior(GO:0035640) |
1.1 | 2.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
1.1 | 3.4 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
1.1 | 22.7 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
1.1 | 3.4 | GO:1902868 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
1.1 | 19.1 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
1.1 | 3.4 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.1 | 28.1 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
1.1 | 4.5 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
1.1 | 3.3 | GO:1904170 | septin ring assembly(GO:0000921) septin ring organization(GO:0031106) regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
1.1 | 6.6 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
1.1 | 1.1 | GO:0070459 | prolactin secretion(GO:0070459) |
1.1 | 3.3 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
1.1 | 3.3 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
1.1 | 7.6 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
1.1 | 9.7 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.1 | 3.2 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.1 | 6.4 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
1.1 | 14.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.1 | 2.1 | GO:0021764 | amygdala development(GO:0021764) |
1.1 | 12.7 | GO:0034465 | response to carbon monoxide(GO:0034465) |
1.1 | 10.5 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.1 | 3.2 | GO:0042704 | uterine wall breakdown(GO:0042704) |
1.1 | 3.2 | GO:0060214 | endocardium formation(GO:0060214) |
1.0 | 22.0 | GO:0001675 | acrosome assembly(GO:0001675) |
1.0 | 4.2 | GO:0036269 | swimming behavior(GO:0036269) |
1.0 | 46.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.0 | 3.1 | GO:0002118 | aggressive behavior(GO:0002118) |
1.0 | 7.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.0 | 3.1 | GO:0002585 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
1.0 | 1.0 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
1.0 | 7.1 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
1.0 | 11.1 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
1.0 | 1.0 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
1.0 | 14.9 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.0 | 1.0 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
1.0 | 3.0 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
1.0 | 2.9 | GO:0060981 | cell migration involved in coronary angiogenesis(GO:0060981) |
1.0 | 7.7 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
1.0 | 1.0 | GO:0070666 | regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
1.0 | 9.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.0 | 10.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
1.0 | 19.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.0 | 12.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
1.0 | 4.8 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.9 | 0.9 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.9 | 1.9 | GO:0048371 | lateral mesodermal cell differentiation(GO:0048371) |
0.9 | 4.7 | GO:1903974 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.9 | 2.8 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.9 | 7.4 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.9 | 3.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.9 | 7.3 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.9 | 2.7 | GO:0060596 | mammary placode formation(GO:0060596) |
0.9 | 7.2 | GO:0021740 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
0.9 | 2.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.9 | 0.9 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.9 | 2.7 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.9 | 0.9 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.9 | 0.9 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.9 | 0.9 | GO:1903859 | regulation of dendrite extension(GO:1903859) |
0.9 | 2.6 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.9 | 7.8 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.9 | 2.6 | GO:0051039 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.9 | 2.6 | GO:1990258 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.9 | 70.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.9 | 4.3 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.8 | 2.5 | GO:0060166 | olfactory pit development(GO:0060166) |
0.8 | 0.8 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.8 | 14.4 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.8 | 5.0 | GO:0086016 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
0.8 | 8.4 | GO:0046541 | saliva secretion(GO:0046541) |
0.8 | 9.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.8 | 4.2 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.8 | 3.3 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
0.8 | 33.6 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.8 | 16.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.8 | 4.1 | GO:0051885 | positive regulation of anagen(GO:0051885) |
0.8 | 0.8 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.8 | 4.0 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.8 | 3.2 | GO:0060723 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.8 | 7.2 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.8 | 5.6 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.8 | 3.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.8 | 3.2 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.8 | 2.4 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.8 | 20.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.8 | 2.4 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
0.8 | 0.8 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.8 | 6.9 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.8 | 10.7 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.8 | 2.3 | GO:1990519 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
0.8 | 0.8 | GO:0008050 | female courtship behavior(GO:0008050) |
0.8 | 6.1 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) |
0.8 | 1.5 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.7 | 10.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.7 | 3.0 | GO:0031456 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.7 | 1.5 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.7 | 4.5 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.7 | 3.0 | GO:0099624 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.7 | 2.2 | GO:1902103 | metaphase/anaphase transition of meiotic cell cycle(GO:0044785) regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902102) negative regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902103) regulation of meiotic chromosome separation(GO:1905132) negative regulation of meiotic chromosome separation(GO:1905133) |
0.7 | 2.2 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.7 | 2.9 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.7 | 3.7 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.7 | 1.5 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.7 | 5.1 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.7 | 6.5 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.7 | 0.7 | GO:0046618 | drug export(GO:0046618) |
0.7 | 5.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.7 | 3.6 | GO:0072190 | ureter urothelium development(GO:0072190) |
0.7 | 2.1 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.7 | 2.1 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
0.7 | 10.7 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.7 | 4.2 | GO:0045762 | positive regulation of adenylate cyclase activity(GO:0045762) |
0.7 | 9.1 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.7 | 2.1 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
0.7 | 4.8 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.7 | 1.4 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.7 | 2.0 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.7 | 10.8 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.7 | 2.7 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.7 | 0.7 | GO:0099612 | protein localization to axon(GO:0099612) |
0.7 | 1.3 | GO:0097106 | postsynaptic density organization(GO:0097106) |
0.7 | 3.9 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.7 | 3.3 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
0.6 | 1.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.6 | 3.2 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.6 | 4.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.6 | 12.7 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.6 | 1.9 | GO:1900276 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.6 | 23.5 | GO:0042551 | neuron maturation(GO:0042551) |
0.6 | 1.9 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.6 | 17.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.6 | 3.8 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.6 | 17.0 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.6 | 3.1 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.6 | 3.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.6 | 4.4 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.6 | 2.5 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.6 | 2.5 | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.6 | 5.0 | GO:0046959 | habituation(GO:0046959) |
0.6 | 4.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.6 | 9.3 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.6 | 10.5 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.6 | 38.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.6 | 10.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.6 | 1.8 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
0.6 | 3.6 | GO:0048664 | neuron fate determination(GO:0048664) |
0.6 | 4.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.6 | 7.2 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.6 | 0.6 | GO:0018963 | phthalate metabolic process(GO:0018963) |
0.6 | 1.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.6 | 4.8 | GO:0021564 | vagus nerve development(GO:0021564) |
0.6 | 5.3 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.6 | 3.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.6 | 1.8 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.6 | 2.9 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.6 | 3.5 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.6 | 7.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.6 | 2.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.6 | 2.9 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.6 | 3.5 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.6 | 2.9 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.6 | 9.7 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.6 | 6.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.6 | 3.4 | GO:0070981 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
0.6 | 2.8 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.6 | 10.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.6 | 0.6 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.6 | 1.1 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.6 | 1.7 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.6 | 0.6 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.6 | 2.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.6 | 6.6 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.6 | 0.6 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.6 | 17.7 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.5 | 3.8 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.5 | 7.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.5 | 2.2 | GO:0019343 | cysteine biosynthetic process from serine(GO:0006535) cysteine biosynthetic process via cystathionine(GO:0019343) |
0.5 | 6.5 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.5 | 1.1 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.5 | 2.6 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.5 | 1.6 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.5 | 2.6 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.5 | 1.0 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.5 | 6.3 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.5 | 2.6 | GO:0044856 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.5 | 0.5 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.5 | 4.2 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.5 | 1.0 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.5 | 15.5 | GO:0033622 | integrin activation(GO:0033622) |
0.5 | 3.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.5 | 2.6 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
0.5 | 0.5 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.5 | 1.5 | GO:0042418 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
0.5 | 11.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.5 | 1.0 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.5 | 1.5 | GO:1901671 | positive regulation of superoxide dismutase activity(GO:1901671) negative regulation of DNA catabolic process(GO:1903625) regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of removal of superoxide radicals(GO:1904833) |
0.5 | 6.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.5 | 1.0 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.5 | 1.5 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.5 | 1.5 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.5 | 2.0 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.5 | 0.5 | GO:0030432 | peristalsis(GO:0030432) |
0.5 | 1.0 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
0.5 | 2.0 | GO:0009386 | translational attenuation(GO:0009386) |
0.5 | 4.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.5 | 0.5 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.5 | 2.9 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.5 | 0.5 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.5 | 1.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.5 | 1.0 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.5 | 2.4 | GO:0007343 | egg activation(GO:0007343) |
0.5 | 1.9 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.5 | 6.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.5 | 2.9 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.5 | 2.9 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.5 | 1.9 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.5 | 6.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.5 | 7.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.5 | 2.8 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.5 | 0.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.5 | 1.9 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.5 | 2.3 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.5 | 1.4 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.5 | 0.5 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.5 | 2.8 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.5 | 0.9 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.5 | 1.8 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.5 | 0.9 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.5 | 2.7 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.5 | 0.5 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.5 | 21.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.5 | 1.8 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.5 | 0.5 | GO:2001074 | regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.4 | 9.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 3.1 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.4 | 2.7 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.4 | 1.8 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.4 | 0.4 | GO:1903061 | regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
0.4 | 4.9 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.4 | 0.4 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.4 | 1.3 | GO:0032849 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.4 | 12.3 | GO:0008038 | neuron recognition(GO:0008038) |
0.4 | 1.3 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.4 | 0.9 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.4 | 2.1 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.4 | 0.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.4 | 22.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.4 | 2.6 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.4 | 2.6 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.4 | 4.7 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.4 | 17.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.4 | 0.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.4 | 2.1 | GO:0014028 | notochord formation(GO:0014028) |
0.4 | 1.3 | GO:0006043 | glucosamine catabolic process(GO:0006043) |
0.4 | 0.4 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.4 | 3.8 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.4 | 13.0 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.4 | 14.6 | GO:0019228 | neuronal action potential(GO:0019228) |
0.4 | 0.8 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.4 | 0.4 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.4 | 2.5 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.4 | 2.5 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.4 | 42.3 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.4 | 2.0 | GO:0061055 | myotome development(GO:0061055) |
0.4 | 43.7 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.4 | 2.4 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.4 | 5.7 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.4 | 4.0 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.4 | 2.4 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
0.4 | 4.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.4 | 5.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.4 | 12.8 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.4 | 23.1 | GO:0008542 | visual learning(GO:0008542) |
0.4 | 15.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.4 | 4.4 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.4 | 1.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.4 | 4.0 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.4 | 1.2 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.4 | 1.2 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.4 | 1.2 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.4 | 1.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.4 | 3.1 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.4 | 4.3 | GO:0060074 | synapse maturation(GO:0060074) |
0.4 | 5.1 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.4 | 26.9 | GO:0003341 | cilium movement(GO:0003341) |
0.4 | 1.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.4 | 1.5 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.4 | 1.2 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.4 | 2.3 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.4 | 11.8 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.4 | 0.4 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.4 | 0.8 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
0.4 | 0.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.4 | 1.9 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.4 | 14.5 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.4 | 3.0 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
0.4 | 1.1 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.4 | 0.4 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.4 | 0.4 | GO:0035412 | regulation of catenin import into nucleus(GO:0035412) |
0.4 | 17.3 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.4 | 1.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.4 | 5.5 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.4 | 1.8 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.4 | 1.5 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.4 | 2.9 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.4 | 2.2 | GO:0051012 | microtubule sliding(GO:0051012) |
0.4 | 1.8 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.4 | 0.4 | GO:0030035 | microspike assembly(GO:0030035) |
0.4 | 1.4 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.4 | 1.1 | GO:0019085 | early viral transcription(GO:0019085) |
0.4 | 2.5 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.4 | 0.7 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.4 | 1.1 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.4 | 23.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.4 | 3.9 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.4 | 4.6 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.4 | 6.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.4 | 1.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 1.0 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.3 | 5.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 2.1 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.3 | 0.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.3 | 3.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.3 | 2.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.3 | 1.7 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.3 | 2.0 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.3 | 0.7 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.3 | 1.0 | GO:0032470 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) relaxation of skeletal muscle(GO:0090076) |
0.3 | 1.3 | GO:1904106 | protein localization to microvillus(GO:1904106) |
0.3 | 1.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.3 | 2.7 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.3 | 3.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 4.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 7.0 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.3 | 3.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.3 | 0.3 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.3 | 0.7 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.3 | 3.6 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.3 | 1.3 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.3 | 1.3 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 1.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.3 | 12.7 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.3 | 2.3 | GO:0021794 | thalamus development(GO:0021794) |
0.3 | 2.9 | GO:0048747 | muscle fiber development(GO:0048747) |
0.3 | 3.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 1.3 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.3 | 1.0 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.3 | 8.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.3 | 0.9 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.3 | 1.9 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.3 | 1.6 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.3 | 5.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.3 | 1.9 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.3 | 1.5 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.3 | 0.3 | GO:1903413 | cellular response to bile acid(GO:1903413) |
0.3 | 2.7 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.3 | 9.4 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.3 | 4.5 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.3 | 2.7 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.3 | 3.3 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.3 | 35.6 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.3 | 0.9 | GO:0044335 | canonical Wnt signaling pathway involved in neural crest cell differentiation(GO:0044335) |
0.3 | 0.6 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.3 | 2.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.3 | 0.3 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.3 | 2.7 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.3 | 0.9 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.3 | 1.2 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.3 | 0.9 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
0.3 | 4.4 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.3 | 0.9 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.3 | 2.6 | GO:0032098 | regulation of appetite(GO:0032098) |
0.3 | 1.2 | GO:0021554 | optic nerve development(GO:0021554) |
0.3 | 6.9 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.3 | 3.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.3 | 0.9 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.3 | 1.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 1.1 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.3 | 15.8 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.3 | 3.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 0.6 | GO:0071657 | positive regulation of granulocyte colony-stimulating factor production(GO:0071657) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
0.3 | 0.8 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.3 | 0.8 | GO:0042756 | drinking behavior(GO:0042756) |
0.3 | 10.3 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.3 | 0.6 | GO:0060998 | regulation of dendritic spine development(GO:0060998) |
0.3 | 2.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.3 | 0.6 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.3 | 1.6 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 1.9 | GO:0032445 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.3 | 0.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 0.5 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.3 | 1.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.3 | 0.8 | GO:0015728 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
0.3 | 0.8 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.3 | 1.0 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.3 | 1.3 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.3 | 1.8 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.3 | 0.5 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.3 | 2.3 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.3 | 0.5 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.3 | 0.8 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.3 | 0.5 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.3 | 3.0 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 2.3 | GO:0045187 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.3 | 1.5 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.3 | 3.0 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.3 | 1.5 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.3 | 2.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 0.8 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
0.3 | 0.8 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
0.3 | 2.8 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.3 | 0.8 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.2 | 0.7 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 0.5 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.2 | 0.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.2 | 0.5 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.2 | 0.2 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.2 | 0.7 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.2 | 1.5 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.2 | 0.7 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
0.2 | 0.2 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.5 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.2 | 2.7 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 9.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.2 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.2 | 2.6 | GO:0060581 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.2 | 5.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 0.7 | GO:1904253 | circadian temperature homeostasis(GO:0060086) positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.2 | 2.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.7 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.2 | 0.7 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.2 | 0.7 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.2 | 4.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.2 | 0.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.5 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.2 | 3.2 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.2 | 3.0 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.2 | 15.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 1.4 | GO:0042335 | cuticle development(GO:0042335) |
0.2 | 1.4 | GO:1990834 | response to odorant(GO:1990834) |
0.2 | 24.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.2 | 0.4 | GO:0061141 | lung ciliated cell differentiation(GO:0061141) |
0.2 | 1.3 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.2 | 1.8 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.2 | 0.9 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 2.6 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 1.3 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.2 | 1.1 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.2 | 2.6 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.2 | 0.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 1.5 | GO:1902022 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
0.2 | 5.8 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.2 | 0.4 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 0.6 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.2 | 0.8 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.2 | 1.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 5.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.6 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
0.2 | 0.4 | GO:0070836 | caveola assembly(GO:0070836) |
0.2 | 0.4 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.2 | 0.8 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.2 | 0.6 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.2 | 4.1 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.2 | 0.4 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.2 | 0.4 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.2 | 1.6 | GO:0035822 | gene conversion(GO:0035822) |
0.2 | 0.4 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.2 | 0.8 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.2 | 4.2 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.2 | 1.6 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.2 | 1.2 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.2 | 1.4 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.2 | 1.6 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.2 | 0.4 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.2 | 1.6 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.2 | 0.2 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.2 | 0.8 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.2 | 1.4 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.2 | 0.6 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.2 | 0.4 | GO:0003015 | heart process(GO:0003015) |
0.2 | 1.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.2 | 4.9 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.2 | 0.4 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.2 | 3.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 1.0 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.2 | 10.8 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.2 | 0.4 | GO:2000018 | regulation of male gonad development(GO:2000018) positive regulation of male gonad development(GO:2000020) |
0.2 | 4.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.2 | 0.6 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.2 | 0.6 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 0.4 | GO:0043474 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.2 | 2.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.2 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.2 | 5.2 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.2 | 1.9 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.2 | 0.2 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.2 | 0.7 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 0.9 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.2 | 0.4 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.2 | 2.4 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 2.8 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 3.8 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.2 | 5.9 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.2 | 3.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.2 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.2 | 5.4 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.2 | 2.5 | GO:0035878 | nail development(GO:0035878) |
0.2 | 0.2 | GO:0044010 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
0.2 | 0.5 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.2 | 13.6 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.2 | 0.9 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.4 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.2 | 1.4 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.2 | 0.2 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.2 | 3.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.5 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 2.8 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.2 | 3.8 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.2 | 1.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.5 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.2 | 4.4 | GO:0097320 | membrane tubulation(GO:0097320) |
0.2 | 0.5 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
0.2 | 1.2 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.2 | 1.9 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 1.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.2 | 5.7 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.2 | 0.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 4.3 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.2 | 0.5 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.9 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.9 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.2 | 2.0 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.2 | 0.5 | GO:0046056 | dADP metabolic process(GO:0046056) |
0.2 | 1.4 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.2 | 0.7 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.2 | 0.3 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
0.2 | 2.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.2 | 2.6 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 3.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 0.7 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 0.5 | GO:0060290 | transdifferentiation(GO:0060290) |
0.2 | 3.1 | GO:0061337 | cardiac conduction(GO:0061337) |
0.2 | 0.3 | GO:0042214 | terpene metabolic process(GO:0042214) |
0.2 | 2.3 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.2 | 0.3 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.2 | 1.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 3.8 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 2.4 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.2 | 1.9 | GO:0043489 | RNA stabilization(GO:0043489) |
0.2 | 1.1 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.2 | 3.7 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.2 | 1.5 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 0.5 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
0.2 | 2.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 1.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 2.1 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.2 | 1.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.2 | 1.1 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.1 | 0.7 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 3.3 | GO:0001754 | eye photoreceptor cell differentiation(GO:0001754) |
0.1 | 0.7 | GO:1903237 | negative regulation of cellular extravasation(GO:0002692) negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 1.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 2.5 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.1 | 0.9 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 1.0 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.1 | 4.0 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 2.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.3 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.1 | 1.2 | GO:0070977 | bone maturation(GO:0070977) |
0.1 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.7 | GO:0072178 | nephric duct morphogenesis(GO:0072178) |
0.1 | 0.7 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.1 | 0.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 2.0 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.4 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.1 | 1.4 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 4.8 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 1.8 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 1.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.6 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.1 | 0.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.7 | GO:0035082 | axoneme assembly(GO:0035082) |
0.1 | 2.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 0.4 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 15.9 | GO:0001764 | neuron migration(GO:0001764) |
0.1 | 3.3 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.5 | GO:0018277 | protein deamination(GO:0018277) |
0.1 | 4.5 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 1.5 | GO:0051231 | spindle elongation(GO:0051231) |
0.1 | 0.7 | GO:0061384 | heart trabecula morphogenesis(GO:0061384) |
0.1 | 2.6 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.5 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.1 | 1.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.1 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.1 | 0.5 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 3.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 3.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.1 | 0.3 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.1 | 0.3 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.1 | 23.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.7 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.1 | 0.7 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.1 | 0.9 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.9 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 2.8 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 1.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.7 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.1 | 0.4 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.1 | GO:1901093 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.1 | 0.5 | GO:0097484 | dendrite extension(GO:0097484) |
0.1 | 0.8 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.3 | GO:0042245 | RNA repair(GO:0042245) |
0.1 | 0.1 | GO:0031247 | actin rod assembly(GO:0031247) |
0.1 | 0.4 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.1 | 0.3 | GO:1903352 | L-ornithine transmembrane transport(GO:1903352) |
0.1 | 0.1 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 1.9 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.4 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 2.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 2.5 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 1.5 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.1 | 2.8 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.1 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.1 | 2.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.4 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.5 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.1 | 0.5 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 1.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.6 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.1 | 0.2 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.1 | 2.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.2 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.1 | 0.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 3.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 10.0 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.1 | 1.6 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.9 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.1 | 7.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 1.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.1 | GO:0050893 | sensory processing(GO:0050893) |
0.1 | 0.7 | GO:0006574 | valine catabolic process(GO:0006574) |
0.1 | 0.6 | GO:0021575 | hindbrain morphogenesis(GO:0021575) |
0.1 | 0.2 | GO:1901376 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.1 | 0.6 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 1.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 1.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.3 | GO:0042377 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
0.1 | 0.4 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 1.3 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.1 | 0.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 1.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.2 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.1 | 1.5 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.4 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 1.0 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.4 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.4 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 0.6 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 1.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.3 | GO:2001113 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
0.1 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 4.7 | GO:0006735 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.1 | 0.3 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.1 | 0.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 7.6 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 | 0.4 | GO:0045649 | regulation of macrophage differentiation(GO:0045649) |
0.1 | 0.6 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.6 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.1 | 1.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.5 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 2.8 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.1 | 5.2 | GO:0009583 | phototransduction(GO:0007602) detection of light stimulus(GO:0009583) |
0.1 | 0.1 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.1 | 2.0 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.1 | 2.7 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 0.5 | GO:0006531 | aspartate metabolic process(GO:0006531) |
0.1 | 0.3 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.3 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.1 | 1.7 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.1 | 0.3 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
0.1 | 0.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.3 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.5 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.3 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.1 | 7.4 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 1.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.6 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.1 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
0.1 | 0.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 1.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.3 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
0.1 | 1.1 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.3 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 1.1 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.1 | 1.7 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.8 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 1.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.9 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.6 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 0.1 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.1 | 0.5 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
0.1 | 13.8 | GO:0098916 | chemical synaptic transmission(GO:0007268) anterograde trans-synaptic signaling(GO:0098916) |
0.1 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.6 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.1 | 0.2 | GO:0031650 | regulation of heat generation(GO:0031650) |
0.1 | 0.4 | GO:0090306 | spindle assembly involved in female meiosis(GO:0007056) spindle assembly involved in meiosis(GO:0090306) |
0.1 | 0.2 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
0.1 | 0.8 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.3 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 2.2 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.1 | 1.7 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 1.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.1 | 1.1 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.1 | 2.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.4 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.2 | GO:0006429 | glutaminyl-tRNA aminoacylation(GO:0006425) leucyl-tRNA aminoacylation(GO:0006429) |
0.1 | 0.4 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.1 | 2.2 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 0.5 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.1 | 0.3 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.2 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.5 | GO:0060996 | dendritic spine development(GO:0060996) |
0.1 | 0.3 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:1902595 | response to sorbitol(GO:0072708) regulation of DNA replication origin binding(GO:1902595) |
0.1 | 0.5 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.2 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 0.3 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.1 | 0.7 | GO:0046661 | male sex differentiation(GO:0046661) |
0.1 | 0.2 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
0.1 | 0.3 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.1 | 0.8 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.1 | 0.3 | GO:1901535 | regulation of DNA demethylation(GO:1901535) |
0.1 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.2 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
0.1 | 0.3 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.1 | 0.3 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.1 | 0.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.4 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.2 | GO:0003188 | heart valve formation(GO:0003188) |
0.1 | 1.6 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.2 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.1 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.1 | 0.2 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.1 | 1.1 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.1 | 0.7 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 0.9 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 1.8 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.1 | 0.2 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 2.4 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.1 | 1.6 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.1 | 1.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.2 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 0.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.5 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.2 | GO:0060629 | regulation of homologous chromosome segregation(GO:0060629) |
0.1 | 1.2 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.2 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.6 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 1.0 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.1 | 0.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.1 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.1 | 0.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.3 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.2 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.1 | 0.4 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.0 | 0.4 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 | 0.2 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.4 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 1.6 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.0 | 0.6 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.7 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.1 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 1.2 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.2 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.0 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 1.1 | GO:0021549 | cerebellum development(GO:0021549) |
0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.1 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.0 | 0.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.2 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.2 | GO:1903613 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
0.0 | 0.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.4 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.3 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.0 | 1.1 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.0 | 0.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.6 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.2 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.2 | GO:0048696 | abscission(GO:0009838) regulation of collateral sprouting in absence of injury(GO:0048696) negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.1 | GO:0035803 | egg coat formation(GO:0035803) |
0.0 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.5 | GO:0097205 | renal filtration(GO:0097205) |
0.0 | 0.9 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.1 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.0 | 0.5 | GO:1904353 | regulation of telomere capping(GO:1904353) |
0.0 | 1.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.7 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.1 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.0 | 0.8 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.1 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.0 | 0.2 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.3 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 1.2 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 1.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0090656 | t-circle formation(GO:0090656) |
0.0 | 0.5 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.3 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.0 | 0.6 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.0 | 0.5 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0006404 | RNA import into nucleus(GO:0006404) snRNA import into nucleus(GO:0061015) |
0.0 | 0.3 | GO:0043578 | nuclear matrix organization(GO:0043578) |
0.0 | 0.5 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.6 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.1 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.0 | 0.3 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.0 | 0.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.2 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.7 | GO:0021762 | substantia nigra development(GO:0021762) |
0.0 | 0.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.1 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.2 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.7 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.2 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.0 | 1.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 2.1 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.0 | 0.0 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.0 | 0.0 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.2 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.6 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.1 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.0 | 0.3 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0007612 | learning(GO:0007612) |
0.0 | 0.1 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.2 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.0 | 0.0 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.1 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
0.0 | 0.1 | GO:0019075 | virus maturation(GO:0019075) |
0.0 | 0.4 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.0 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.0 | 0.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 0.1 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.0 | 0.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.1 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 3.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.1 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.2 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.0 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.0 | 0.1 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.0 | 0.0 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.0 | 0.0 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
0.0 | 0.1 | GO:0003231 | cardiac ventricle development(GO:0003231) |
0.0 | 0.1 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.4 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.1 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.0 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 18.9 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
4.7 | 18.8 | GO:0072534 | perineuronal net(GO:0072534) |
4.6 | 46.4 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
3.4 | 10.3 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
2.8 | 16.7 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
2.7 | 51.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
2.5 | 9.9 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
2.3 | 7.0 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
2.2 | 39.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
2.2 | 8.7 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
2.0 | 79.4 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
2.0 | 61.9 | GO:0043194 | axon initial segment(GO:0043194) |
1.9 | 1.9 | GO:0044301 | climbing fiber(GO:0044301) |
1.8 | 1.8 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
1.7 | 92.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.7 | 31.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.7 | 6.9 | GO:0060187 | cell pole(GO:0060187) |
1.7 | 6.8 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
1.7 | 21.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.6 | 23.0 | GO:0033269 | internode region of axon(GO:0033269) |
1.6 | 4.8 | GO:0098855 | HCN channel complex(GO:0098855) |
1.6 | 1.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
1.6 | 14.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.6 | 10.9 | GO:0014802 | terminal cisterna(GO:0014802) |
1.4 | 4.3 | GO:0005584 | collagen type I trimer(GO:0005584) |
1.4 | 10.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.4 | 25.4 | GO:0031209 | SCAR complex(GO:0031209) |
1.4 | 9.6 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.3 | 4.0 | GO:0044305 | calyx of Held(GO:0044305) |
1.3 | 14.1 | GO:0071953 | elastic fiber(GO:0071953) |
1.3 | 1.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.3 | 6.3 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
1.2 | 13.5 | GO:0032584 | growth cone membrane(GO:0032584) |
1.2 | 3.7 | GO:0001534 | radial spoke(GO:0001534) |
1.2 | 29.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.2 | 15.9 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.2 | 4.8 | GO:0097450 | astrocyte end-foot(GO:0097450) |
1.2 | 70.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.1 | 7.7 | GO:0045298 | tubulin complex(GO:0045298) |
1.1 | 3.2 | GO:0097447 | dendritic tree(GO:0097447) |
1.1 | 6.4 | GO:0031673 | H zone(GO:0031673) |
1.1 | 8.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.0 | 11.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.0 | 17.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.0 | 20.5 | GO:0005861 | troponin complex(GO:0005861) |
1.0 | 5.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
1.0 | 2.0 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
1.0 | 14.6 | GO:0043083 | synaptic cleft(GO:0043083) |
1.0 | 194.9 | GO:0043204 | perikaryon(GO:0043204) |
0.9 | 7.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.9 | 7.3 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.9 | 1.8 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.9 | 19.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.9 | 15.0 | GO:0032590 | dendrite membrane(GO:0032590) |
0.9 | 3.5 | GO:0031213 | RSF complex(GO:0031213) |
0.8 | 3.4 | GO:0016013 | syntrophin complex(GO:0016013) |
0.8 | 7.6 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.8 | 2.5 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.8 | 101.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.8 | 70.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.8 | 0.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.8 | 6.9 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.8 | 3.0 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
0.8 | 6.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.7 | 9.0 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.7 | 3.7 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.7 | 7.4 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.7 | 2.2 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.7 | 2.1 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.7 | 3.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.7 | 8.4 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.7 | 10.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.7 | 17.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.7 | 3.4 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.7 | 18.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.6 | 3.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.6 | 1.3 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.6 | 1.9 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.6 | 29.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.6 | 10.1 | GO:0008091 | spectrin(GO:0008091) |
0.6 | 1.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.6 | 2.4 | GO:0030849 | autosome(GO:0030849) |
0.6 | 1.2 | GO:0043291 | RAVE complex(GO:0043291) |
0.6 | 5.9 | GO:0060076 | excitatory synapse(GO:0060076) |
0.6 | 2.9 | GO:1990742 | microvesicle(GO:1990742) |
0.6 | 3.5 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.6 | 23.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.6 | 2.8 | GO:0097441 | basilar dendrite(GO:0097441) |
0.6 | 3.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.6 | 5.5 | GO:0016589 | NURF complex(GO:0016589) |
0.5 | 16.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 1.6 | GO:0070702 | inner mucus layer(GO:0070702) outer mucus layer(GO:0070703) |
0.5 | 8.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.5 | 3.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.5 | 1.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.5 | 56.2 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.5 | 1.0 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.5 | 4.0 | GO:1990393 | 3M complex(GO:1990393) |
0.5 | 4.0 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.5 | 1.5 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.5 | 18.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.5 | 144.4 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.4 | 6.7 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.4 | 1.8 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.4 | 12.4 | GO:0005922 | connexon complex(GO:0005922) |
0.4 | 2.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.4 | 0.4 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.4 | 10.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 2.9 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.4 | 14.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.4 | 5.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.4 | 2.9 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.4 | 3.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.4 | 5.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 0.4 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.4 | 1.6 | GO:0032982 | myosin filament(GO:0032982) |
0.4 | 12.2 | GO:0005605 | basal lamina(GO:0005605) |
0.4 | 0.4 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.4 | 5.0 | GO:0030478 | actin cap(GO:0030478) |
0.4 | 2.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.4 | 7.6 | GO:0043203 | axon hillock(GO:0043203) |
0.4 | 7.5 | GO:0000800 | lateral element(GO:0000800) |
0.4 | 1.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.4 | 20.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.4 | 89.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.4 | 1.1 | GO:0033011 | perinuclear theca(GO:0033011) |
0.4 | 2.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.4 | 1.8 | GO:0036156 | inner dynein arm(GO:0036156) |
0.4 | 1.4 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.4 | 0.7 | GO:0005883 | neurofilament(GO:0005883) |
0.4 | 13.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.3 | 0.7 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 1.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 2.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.3 | 5.8 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.3 | 1.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.3 | 3.6 | GO:0001939 | female pronucleus(GO:0001939) |
0.3 | 46.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 9.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 11.1 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.3 | 6.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.3 | 0.9 | GO:0034705 | potassium channel complex(GO:0034705) |
0.3 | 0.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.3 | 0.6 | GO:0070701 | mucus layer(GO:0070701) |
0.3 | 0.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.3 | 1.6 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.3 | 0.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.3 | 1.2 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 3.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 3.3 | GO:0097060 | synaptic membrane(GO:0097060) |
0.3 | 20.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 1.7 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 0.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.3 | 4.8 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.3 | 2.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 4.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.3 | 0.8 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.3 | 3.0 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 0.5 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.2 | 0.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 0.7 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 1.2 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 17.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 53.2 | GO:0030424 | axon(GO:0030424) |
0.2 | 7.7 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 1.9 | GO:0002177 | manchette(GO:0002177) |
0.2 | 33.8 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 0.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 6.2 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 2.7 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 0.9 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.2 | 19.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 9.0 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 14.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 1.6 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.2 | 0.7 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.2 | 1.3 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.2 | 4.5 | GO:0097227 | sperm annulus(GO:0097227) |
0.2 | 0.4 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.2 | 4.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 1.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 1.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 48.9 | GO:0098793 | presynapse(GO:0098793) |
0.2 | 3.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 5.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 1.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.6 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.2 | 2.7 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 19.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 1.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 7.8 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 2.6 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 2.8 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 2.5 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 1.0 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.2 | 1.5 | GO:0000801 | central element(GO:0000801) |
0.2 | 1.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 0.4 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.2 | 3.3 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.2 | 1.7 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 1.2 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.2 | 1.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 1.1 | GO:0090661 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 47.8 | GO:0045202 | synapse(GO:0045202) |
0.2 | 2.3 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 2.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 15.0 | GO:0060170 | ciliary membrane(GO:0060170) |
0.2 | 4.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 0.3 | GO:0019034 | viral replication complex(GO:0019034) |
0.2 | 0.5 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.2 | 0.5 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.2 | 0.5 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.2 | 0.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 1.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 19.2 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.1 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 1.0 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 31.7 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 6.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 30.6 | GO:0030017 | sarcomere(GO:0030017) |
0.1 | 2.2 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.9 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.1 | 1.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.9 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.5 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 4.8 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 2.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.1 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
0.1 | 0.4 | GO:0035101 | FACT complex(GO:0035101) |
0.1 | 1.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.8 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 7.4 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.6 | GO:0032301 | MutSalpha complex(GO:0032301) |
0.1 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 1.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.6 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 11.3 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 2.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 2.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.6 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.1 | 1.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 38.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 3.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 14.9 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.3 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 6.1 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 2.7 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.1 | 0.4 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.1 | 3.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 5.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 2.2 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 3.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.8 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 6.5 | GO:0005929 | cilium(GO:0005929) |
0.1 | 0.4 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 2.0 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 0.4 | GO:0032044 | DSIF complex(GO:0032044) |
0.1 | 0.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 2.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 2.5 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 10.3 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 3.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 1.3 | GO:0031984 | organelle subcompartment(GO:0031984) |
0.1 | 1.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.7 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 0.7 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.2 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.1 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.4 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.1 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 1.4 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 5.4 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.0 | 0.5 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.0 | 0.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.6 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 2.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.6 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.3 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 1.7 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.5 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.4 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.1 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
0.0 | 1.3 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 1.0 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.0 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 0.1 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.0 | 0.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 0.1 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.2 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.0 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 1.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 2.2 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 3.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.0 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.5 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 1.9 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.1 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 2.2 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.3 | GO:0032421 | stereocilium bundle(GO:0032421) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 20.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
3.9 | 3.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
3.8 | 15.4 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
3.7 | 14.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
3.5 | 45.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.4 | 10.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
3.2 | 25.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.9 | 8.7 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
2.9 | 8.6 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
2.8 | 19.9 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
2.8 | 42.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
2.6 | 5.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
2.5 | 20.2 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
2.5 | 14.9 | GO:0097001 | ceramide binding(GO:0097001) |
2.5 | 14.8 | GO:0034711 | inhibin binding(GO:0034711) |
2.2 | 35.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.2 | 19.7 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
2.2 | 43.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
2.1 | 10.5 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
2.1 | 18.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.0 | 38.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
2.0 | 12.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
2.0 | 10.1 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
2.0 | 5.9 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
1.9 | 28.8 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
1.9 | 7.6 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
1.9 | 11.3 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
1.9 | 50.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.9 | 1.9 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
1.8 | 7.2 | GO:1990175 | EH domain binding(GO:1990175) |
1.8 | 5.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
1.8 | 5.3 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
1.7 | 8.6 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
1.7 | 15.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.7 | 13.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.6 | 4.9 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
1.6 | 34.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.6 | 6.4 | GO:0099609 | microtubule lateral binding(GO:0099609) |
1.6 | 9.5 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
1.6 | 4.7 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
1.6 | 4.7 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
1.5 | 6.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.5 | 6.1 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
1.5 | 16.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.5 | 13.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.5 | 5.9 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.5 | 1.5 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
1.4 | 5.8 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
1.4 | 12.9 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
1.4 | 4.3 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
1.4 | 11.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.4 | 14.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
1.4 | 42.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.3 | 4.0 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
1.3 | 11.8 | GO:0042835 | BRE binding(GO:0042835) |
1.3 | 7.7 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
1.3 | 7.6 | GO:0052843 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
1.3 | 39.2 | GO:0031005 | filamin binding(GO:0031005) |
1.2 | 1.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.2 | 6.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.2 | 11.2 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.2 | 6.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
1.2 | 9.9 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
1.2 | 8.6 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.2 | 3.7 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
1.2 | 6.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
1.2 | 3.7 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
1.2 | 14.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.2 | 4.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.2 | 16.5 | GO:0031014 | troponin T binding(GO:0031014) |
1.2 | 22.3 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
1.2 | 7.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.2 | 9.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.2 | 25.4 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
1.1 | 41.9 | GO:0030506 | ankyrin binding(GO:0030506) |
1.1 | 3.4 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
1.1 | 8.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.1 | 5.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.1 | 2.2 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
1.1 | 5.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
1.1 | 5.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.1 | 8.6 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
1.1 | 10.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
1.1 | 60.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.1 | 10.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.1 | 4.2 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
1.0 | 4.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.0 | 3.1 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
1.0 | 29.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
1.0 | 36.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
1.0 | 10.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.0 | 14.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
1.0 | 30.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
1.0 | 10.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.0 | 8.7 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.9 | 3.8 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.9 | 5.6 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.9 | 3.7 | GO:0035939 | microsatellite binding(GO:0035939) |
0.9 | 9.2 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.9 | 8.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.9 | 3.6 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.9 | 12.3 | GO:0008430 | selenium binding(GO:0008430) |
0.9 | 10.5 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.9 | 2.6 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.9 | 5.1 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.9 | 6.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.8 | 11.9 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.8 | 11.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.8 | 7.4 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.8 | 4.9 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.8 | 1.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.8 | 16.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.8 | 5.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.8 | 9.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.8 | 2.3 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
0.8 | 7.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.8 | 2.3 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.8 | 3.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.8 | 19.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.7 | 3.0 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.7 | 6.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.7 | 6.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.7 | 3.0 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.7 | 5.9 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.7 | 2.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.7 | 4.4 | GO:0051373 | FATZ binding(GO:0051373) |
0.7 | 12.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.7 | 2.8 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.7 | 7.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.7 | 5.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.7 | 6.2 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.7 | 10.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.7 | 2.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.7 | 3.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.7 | 7.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.7 | 3.4 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.7 | 1.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.7 | 20.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.7 | 4.0 | GO:1902444 | riboflavin binding(GO:1902444) |
0.7 | 3.9 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
0.7 | 3.3 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.6 | 1.9 | GO:0030984 | kininogen binding(GO:0030984) |
0.6 | 3.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.6 | 1.3 | GO:0030172 | troponin C binding(GO:0030172) |
0.6 | 14.7 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.6 | 24.8 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.6 | 2.5 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.6 | 4.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.6 | 1.8 | GO:0035643 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
0.6 | 2.4 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.6 | 2.4 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.6 | 7.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.6 | 3.0 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.6 | 1.8 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.6 | 2.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.6 | 6.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.6 | 11.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.6 | 3.0 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.6 | 5.3 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.6 | 2.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.6 | 0.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.6 | 7.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.6 | 10.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.6 | 16.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.6 | 2.3 | GO:0005115 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
0.6 | 2.9 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.6 | 2.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.6 | 2.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.6 | 6.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.6 | 1.7 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
0.6 | 1.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.6 | 0.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.5 | 15.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.5 | 2.2 | GO:0016662 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
0.5 | 13.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.5 | 2.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 2.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.5 | 3.7 | GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
0.5 | 1.0 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.5 | 4.6 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.5 | 1.5 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.5 | 1.5 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
0.5 | 1.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.5 | 4.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.5 | 5.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.5 | 6.4 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.5 | 2.9 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.5 | 13.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.5 | 5.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.5 | 3.4 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.5 | 9.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.5 | 4.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.5 | 2.8 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.5 | 0.9 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.5 | 1.9 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.5 | 14.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.5 | 1.8 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
0.4 | 1.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.4 | 16.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.4 | 14.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.4 | 6.4 | GO:0015250 | water channel activity(GO:0015250) |
0.4 | 18.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 1.3 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.4 | 1.3 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.4 | 16.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.4 | 1.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.4 | 5.9 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.4 | 7.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.4 | 2.9 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.4 | 4.4 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.4 | 1.2 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.4 | 78.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.4 | 2.4 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.4 | 1.2 | GO:0038100 | nodal binding(GO:0038100) |
0.4 | 7.0 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.4 | 5.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.4 | 2.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 13.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.4 | 16.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.4 | 2.7 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.4 | 5.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 0.4 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.4 | 1.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.4 | 7.1 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.4 | 1.9 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.4 | 1.4 | GO:0038132 | neuregulin binding(GO:0038132) |
0.4 | 2.5 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.4 | 0.7 | GO:0005113 | patched binding(GO:0005113) |
0.4 | 7.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.4 | 2.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.4 | 7.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 0.7 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.3 | 1.4 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
0.3 | 6.9 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.3 | 10.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 3.0 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.3 | 21.5 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.3 | 30.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.3 | 34.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 2.3 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.3 | 3.9 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 5.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 4.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 1.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 2.8 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.3 | 1.8 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.3 | 5.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 11.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.3 | 0.6 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.3 | 2.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.3 | 1.8 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.3 | 2.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 1.5 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.3 | 6.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 4.6 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.3 | 3.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.3 | 0.8 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.3 | 3.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 5.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 0.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.3 | 1.1 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.3 | 10.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 0.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 1.9 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.3 | 5.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.3 | 11.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.3 | 1.6 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.3 | 5.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 0.8 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
0.3 | 9.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 0.8 | GO:0047661 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
0.3 | 1.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 10.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 2.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 3.9 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.3 | 2.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.3 | 0.5 | GO:0038025 | reelin receptor activity(GO:0038025) |
0.2 | 3.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 5.6 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.2 | 1.0 | GO:0004040 | amidase activity(GO:0004040) |
0.2 | 2.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 0.7 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.2 | 2.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 2.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 1.9 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.2 | 0.9 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 2.1 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.2 | 2.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 2.5 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.2 | 0.7 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.2 | 0.9 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 5.6 | GO:0043236 | laminin binding(GO:0043236) |
0.2 | 1.3 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.2 | 0.9 | GO:0017129 | triglyceride binding(GO:0017129) |
0.2 | 0.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 0.9 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 1.7 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 3.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 19.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.2 | 0.2 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.2 | 1.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 1.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 2.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 2.3 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 1.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 21.2 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 0.6 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
0.2 | 11.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 1.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.6 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
0.2 | 3.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.6 | GO:0052894 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
0.2 | 1.0 | GO:0052836 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.2 | 3.3 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 2.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 7.6 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 4.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 1.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 7.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 0.6 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.2 | 1.6 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.2 | 11.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 14.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 11.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.2 | 13.0 | GO:0019905 | syntaxin binding(GO:0019905) |
0.2 | 1.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.5 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.2 | 1.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 1.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.5 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.2 | 1.8 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.2 | 2.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 3.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 2.4 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.2 | 5.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 5.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 2.0 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.2 | 12.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 0.7 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 4.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.2 | 0.3 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 2.0 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.2 | 2.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 1.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 1.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 0.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 0.3 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
0.2 | 3.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 0.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 0.6 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.2 | 1.0 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.2 | 4.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.5 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.2 | 1.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 0.9 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.2 | 3.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.6 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.1 | 1.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 1.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 1.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 1.0 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 45.2 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.7 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 1.7 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.6 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.1 | 0.4 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 4.3 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 7.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 1.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 1.4 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 29.2 | GO:0005516 | calmodulin binding(GO:0005516) |
0.1 | 1.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 2.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.7 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.1 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.1 | 0.5 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
0.1 | 0.5 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 1.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 5.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.1 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 1.6 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.4 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 1.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 15.6 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 2.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.4 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.7 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.1 | 0.6 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 0.6 | GO:0032143 | single thymine insertion binding(GO:0032143) |
0.1 | 0.8 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 1.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.6 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 1.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.7 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.1 | 0.4 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.1 | 0.5 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.1 | 0.8 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.1 | 0.4 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.7 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.5 | GO:0052829 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
0.1 | 0.3 | GO:0008431 | vitamin E binding(GO:0008431) |
0.1 | 0.3 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 90.1 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 7.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 1.9 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 0.3 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.1 | 1.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.2 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.1 | 1.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 1.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.6 | GO:0043295 | glutathione binding(GO:0043295) |
0.1 | 0.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.3 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.1 | 6.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 1.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 2.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 7.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 2.1 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 1.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 2.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.5 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.1 | 0.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.3 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 2.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.5 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 0.3 | GO:0004423 | iduronate-2-sulfatase activity(GO:0004423) |
0.1 | 0.7 | GO:0000832 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 1.8 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 2.8 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.1 | 2.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 2.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.3 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.1 | 0.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 1.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 2.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.2 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.1 | 0.7 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.6 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.8 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.4 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.1 | 0.4 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 0.4 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.1 | 0.7 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 1.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 4.3 | GO:0005254 | chloride channel activity(GO:0005254) |
0.1 | 0.9 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 5.0 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.2 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 0.9 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.2 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
0.1 | 0.3 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.9 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.2 | GO:0047536 | 2-aminoadipate transaminase activity(GO:0047536) |
0.1 | 0.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.9 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.4 | GO:0051748 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
0.1 | 0.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.7 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 1.8 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.2 | GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0045145) double-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0051908) |
0.1 | 0.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.2 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
0.1 | 0.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 3.3 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 1.9 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 1.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.4 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.1 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.2 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
0.1 | 0.9 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.5 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.0 | 0.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.0 | 1.3 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.6 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.1 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.0 | 8.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 3.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.1 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.0 | 5.2 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
0.0 | 0.0 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.0 | 2.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 1.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 1.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.4 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 1.8 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.7 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 1.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.3 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 1.9 | GO:0015631 | tubulin binding(GO:0015631) |
0.0 | 10.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 3.5 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 11.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.9 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.2 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.2 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.0 | 0.1 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 1.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.0 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.1 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.0 | 0.1 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.0 | 0.2 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.3 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.0 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.2 | GO:0030594 | neurotransmitter receptor activity(GO:0030594) |
0.0 | 0.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 0.0 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.0 | 0.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.1 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.0 | 0.1 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.1 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 3.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.0 | GO:0008527 | taste receptor activity(GO:0008527) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 66.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.8 | 20.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.7 | 2.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.6 | 2.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.5 | 8.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.5 | 36.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.5 | 24.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.5 | 34.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 14.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 20.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 11.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.4 | 19.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.4 | 12.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.4 | 4.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 17.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 38.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.3 | 5.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 7.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 14.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 7.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 7.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 16.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 5.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 5.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 25.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 0.7 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 6.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 7.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 70.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 0.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 5.0 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 8.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 1.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 7.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 6.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 11.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 5.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 4.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 5.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 10.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.2 | 2.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 3.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 13.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 2.4 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 1.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 6.9 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 9.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 1.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 2.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 3.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 2.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 2.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 5.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 38.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.9 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 3.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 2.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 1.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 1.1 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 78.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.9 | 47.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.6 | 4.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
1.4 | 2.9 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
1.4 | 55.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.3 | 55.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.3 | 68.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.1 | 25.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.1 | 30.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.0 | 52.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.0 | 16.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.9 | 62.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.8 | 20.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.8 | 52.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.8 | 35.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.7 | 42.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.7 | 18.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.7 | 27.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 19.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.6 | 14.9 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.6 | 19.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.6 | 5.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.6 | 9.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.5 | 38.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.5 | 20.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.5 | 28.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.5 | 24.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.5 | 7.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.5 | 2.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.4 | 12.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.4 | 20.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.4 | 6.7 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.4 | 8.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.4 | 11.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.4 | 3.6 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.4 | 6.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 21.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 7.5 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.3 | 4.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 22.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 0.6 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.3 | 9.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 15.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 4.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.3 | 0.8 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.3 | 0.8 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.3 | 4.5 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.3 | 6.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 2.4 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.3 | 5.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.3 | 12.1 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 5.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 1.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 4.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 12.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 12.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 12.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 7.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 6.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 3.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 2.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 1.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 6.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 2.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 4.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.9 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 4.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 3.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 2.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.9 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 5.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 10.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 1.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 1.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 3.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 3.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 3.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 3.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 4.3 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 2.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 3.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 10.3 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.1 | 4.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 14.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 1.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 3.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 1.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 3.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.5 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.1 | 2.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.4 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.1 | 0.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 2.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 1.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 4.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 1.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 1.9 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.1 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.0 | 0.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 11.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 2.5 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 1.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.9 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 1.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.2 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 1.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.8 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 4.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |